HOLMES SCOTT A (Chief Financial Officer) sold 0.8% of their position (1.25K shares) of KERYX BIOPHARMACEUTICALS INC on the open market
Open‑market sale worth $3.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/30/2018ACC: 0001114220-18-000099
Officer· Chief Financial Officer
Since Jul 2018
-1.25K
Net shares
Net seller
$3.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.25K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.25K
Price / share
$3.07
Trade value
$3.85K
% of position
0.8%
10/29/2018
165.37K→164.11K
Total
Net shares
−1.25K
Net value
-$3.85K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/29/2018 | S · Sale | −1.25K | $3.07 | $3.85K | 0.8% | 165.37K | 164.11K |
| Total | −1.25K | -$3.85K | ||||||
Derivative Transactions0
No derivative transactions reported